Literature DB >> 10738726

[Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference].

J P Gisbert1, X Calvet, F Gomollón, R Sáinz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10738726     DOI： 10.1016/s0025-7753(00)71237-1

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  10 in total

1.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 2.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 3.  Potent gastric acid inhibition in Helicobacter pylori eradication.

Authors:  Javier P Gisbert
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Optimising acid inhibition treatment.

Authors:  Fernando Gomollón; Xavier Calvet
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Rabeprazole: an update of its use in acid-related disorders.

Authors:  C I Carswell; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.

Authors:  Orhan Sezgin; Mehmet Kasım Aydın; Asena Ayça Özdemir; Arzu Emine Kanık
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

7.  Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital.

Authors:  Siok-Siong Ching; Sivakumaran Sabanathan; Lloyd-R Jenkinson
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

8.  Rescue Therapy for Helicobacter pylori Infection 2012.

Authors:  Javier P Gisbert
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

9.  Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.

Authors:  Jing Su; Xiaoying Zhou; Han Chen; Bo Hao; Weifeng Zhang; Guoxin Zhang
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

10.  Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication.

Authors:  Jai Hoon Yoon; Gwang Ho Baik; Yeon Soo Kim; Ki Tae Suk; Woon Geon Shin; Kyung Ho Kim; Kyoung Oh Kim; Cheol Hee Park; Il Hyun Baik; Hyun Joo Jang; Jin Bong Kim; Sea Hyub Kae; Dong Joon Kim; Hak Yang Kim
Journal:  Gut Liver       Date:  2012-10-18       Impact factor: 4.519
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.